Related Experiment Video
Updated: Sep 26, 2025

Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice
Published on: January 16, 2013
Polychlorinated Biphenyls and Pulmonary Hypertension
Hamza Assaggaf1, Changwon Yoo2, Roberto G Lucchini3,4
1Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah 21955, Saudi Arabia.
Higher polychlorinated biphenyls (PCBs) levels are linked to increased pulmonary arterial hypertension (PAH) risk. This study found greater PCB exposure and body burden in PAH subjects, highlighting environmental factors in hypertension development.
Area of Science:
- Environmental Health
- Toxicology
- Cardiovascular Epidemiology
Background:
- Polychlorinated biphenyls (PCBs) are persistent environmental pollutants with known carcinogenicity.
- Previous studies link PCBs to lung toxicity and hypertension.
- The association between PCB exposure and pulmonary hypertension risk requires further investigation.
Purpose of the Study:
- To evaluate the association between higher exposure to specific PCB congeners and the risk of pulmonary hypertension.
- To compare serum PCB levels in subjects with and without risk factors for pulmonary arterial hypertension (PAH).
Main Methods:
- Cross-sectional analysis of 284 subjects with PAH risk factors and 4210 control subjects.
- Utilized data from the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
- Compared serum PCB levels, adjusting for age, race, BMI, and gender.
Main Results:
- Significantly higher serum PCB levels were observed in PAH subjects compared to controls (e.g., PCB74 GM: 15.91 vs. 11.48 ng/g).
- PCB levels increased with age in the 20-59 age group, with higher PCB180 GM in PAH subjects.
- Higher body burden of specific PCB congeners (PCB153, PCB138, PCB180, PCB118) and increased odds of PAH (e.g., PCB99 OR: 1.5) were noted.
Conclusions:
- Exposure and body burden of PCBs were higher in individuals with PAH risk factors.
- PCB congeners accumulate with age, suggesting long-term exposure impacts.
- Further molecular epidemiologic studies are needed to confirm the role of PCBs in pulmonary arterial hypertension development, acknowledging data limitations.
More Related Videos
07:11Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
Published on: May 23, 2025
12:24Laboratory Estimation of Net Trophic Transfer Efficiencies of PCB Congeners to Lake Trout Salvelinus namaycush from Its Prey
Published on: August 29, 2014
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: